| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,242 |
2,906 |
$137K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,886 |
3,381 |
$95K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,310 |
1,157 |
$66K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
386 |
355 |
$19K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,155 |
1,062 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,443 |
2,225 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
5,993 |
5,038 |
$17K |
| 80061 |
Lipid panel |
1,056 |
969 |
$14K |
| 80053 |
Comprehensive metabolic panel |
1,250 |
1,152 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,051 |
539 |
$12K |
| 86328 |
|
516 |
470 |
$11K |
| 86738 |
|
800 |
769 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
207 |
186 |
$6K |
| 81001 |
|
1,295 |
1,201 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
448 |
405 |
$4K |
| 87276 |
|
278 |
273 |
$4K |
| 87275 |
|
258 |
254 |
$3K |
| 82274 |
|
72 |
59 |
$1K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
33 |
25 |
$538.51 |
| 82043 |
|
57 |
50 |
$332.27 |
| 84436 |
|
32 |
32 |
$203.13 |
| 84479 |
|
31 |
31 |
$184.88 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
239 |
236 |
$0.00 |